TCR 产品代理

产品分类 > 临床研究 > TCR 产品代理

TCR 产品代理

我们很自豪能够率先开发使用 T 细胞受体 (TCR) 复合物来对抗实体瘤和血液系统恶性肿瘤的新型疗法。我们独特的 TRuC-T 细胞利用整个 TCR 复合体的信号传导,独立于 HLA 类型,特异性识别和杀死癌细胞,扩大患者的可能性。
价格: 0.00

OUR PIPELINE


We’re proud to be pioneering the development of novel therapies that use the T-cell receptor (TCR) complex to fight both solid tumors and hematologic malignancies. Our unique TRuC-T cells harness signaling from the entire TCR complex, independent of HLA type, to specifically recognize and kill cancer cells, expanding the possibilities for patients.